Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Genocea Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - GNCA



NEW YORK, Dec. 16, 2017 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Genocea Biosciences, Inc. ("Genocea" or the "Company") (NASDAQ:  GNCA) and certain of its officers.   The class action, filed in United States District Court, for the District of Massachusetts, and docketed under 17-cv-12168, is on behalf of a class consisting of investors who purchased or otherwise acquired Genocea securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Genocea securities between May 5, 2017, and September 25, 2017, both dates inclusive, you have until January 2, 2018 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased. 

[Click here to join this class action]

Genocea is a biopharmaceutical company that discovers and develops vaccines and immunotherapies.  At all relevant times, Genocea's genital herpes immunotherapy product GEN-003 was the Company's lead product candidate.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that:  (i) the Company's finances were insufficient to support Phase 3 trials of GEN-003; (ii) accordingly, Genocea had overstated the prospects for GEN-003; and (iii) as a result of the foregoing, Genocea's public statements were materially false and misleading at all relevant times.   

On September 25, 2017, post-market, Genocea disclosed that it was halting spending and activities on GEN-003 and exploring strategic alternatives for the drug. The Company also announced that it was cutting 40% of its workforce.

On this news, the Company's share price fell $4.08, or 76.5%, to close at $1.25 on September 26, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

SOURCE Pomerantz LLP


These press releases may also interest you

at 03:00
RIVERSIDE, Ill., June 22, 2018 Zeigler Automotive Group today announced its 26th dealership acquisition after officially purchasing its fourth Ford dealership location, McCarthy Ford of North Riverside, from Ray and John LeFevour. McCarthy Ford of...

at 03:00
Royal DSM, a global science-based company active in health, nutrition and materials, has repurchased 324,894 of its own shares in the period from 15 June 2018 up to and including 20 June 2018 at an average price of ?88.18. This is in accordance...

at 02:58
Nordic sneaker brand ARKK Copenhagen announces a multi-million-dollar (USD) Series A deal with Copenhagen-based Friheden Invest?backers of By Malene Birger and Tiger of Sweden?and North-East Venture?an establishment of the founding partners behind...

at 02:45
BestVPN.com has seen a 131% increase in Turkish traffic in the past 24 hours In the lead up to Turkey's snap election, frustration is growing over widespread digital censorship by the ruling AKP party.      (Logo:...

at 01:14
Asetek, the leader in providing flexible liquid cooling for HPC clusters and Data Centers and Quanta Cloud Technology (QCT), a world leading Data Center solutions provider, revealed today the use of the latest Asetek heat rejection technology at the...

at 01:00
LONDON, June 22, 2018 /PRNewswire-PRWeb/ -- Anifa launched its Kickstarter campaign today for its waterproof TechKnit jacket. Anifa's aim is to provide a more comfortable, stretchable fabric than any other waterproof outerwear on the market, all...




News published on 16 december 2017 at 20:00 and distributed by: